Dexamfetamine, a regulated substance, is employed in Australia primarily for the management of Attention-Deficit/Hyperactivity Disorder (ADHD) and, less frequently , narcolepsy. Its use is strictly monitored under the Therapeutic Goods Act and requires a recent prescription from an authorized medical professional . While it can provide significant